Religious leaders and diabetes prevention in Bangladesh

ISRCTN ISRCTN91564707
DOI https://doi.org/10.1186/ISRCTN91564707
Secondary identifying numbers BADAS-ERC/EC 122100330
Submission date
24/04/2022
Registration date
08/05/2022
Last edited
09/05/2022
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
Type 2 diabetes is a common condition that causes the level of sugar (glucose) in the blood to become too high.
Type 2 diabetes (T2DM) and related non-communicable diseases (NCDs) are common among the adult population in Bangladesh, which can be prevented through lifestyle modification. Evidence shows that culturally sensitive and behaviorally oriented faith-based intervention by religious leaders affects the prevention of T2DM and related NCDs.
Aim: To assess the outcome of faith-based intervention for the prevention of T2DM in high-risk subjects in Bangladesh.

Who can participate?
All individuals aged 25 years or older with diabetes risk score 9 or above and diagnosed with prediabetes (IFG/IGT) as per WHO recommended diagnostic value, permanent residents and willing to participate and available for 12 months of study.

What does the study involve?
Over the course of 12 months, this study will involve counseling, biophysical measurement, and laboratory investigations related to the study outcomes. In the intervention group, participants will visit twelve times (one each month) for counseling with religious leaders. They will discuss healthy lifestyles based on the religious sermon (khutbah) that benefits T2DM prevention. In addition, they will have three appointments (at the time of registration, 4 months, and 12 months) for structured healthy lifestyle education (including diet and physical activity) effective for T2DM prevention, biophysical measurement, and laboratory investigations with researchers from the Centre for Global Health Research of the Diabetic Association of Bangladesh. They will complete a questionnaire on changes in major nutritional and exercise habits and also the changes in Knowledge, Attitude, and Practice (KAP). All these appointments will be face-to-face. The subjects in the control group will be informed about a healthy lifestyle based on the religious sermon (khutbah). After the inclusion and collection of baseline data, they will visit the study site at 4 months and 12 months for the collection of anthropometric, clinical, and laboratory investigations. They will also complete a questionnaire on changes in major nutritional and exercise habits and also the changes in KAP.

What are the possible benefits and risks of participating?
This proposed study will fill up the gap in our existing knowledge by testing the effectiveness of faith-based intervention by religious leaders for the prevention of T2DM and related NCDs. No risk will be involved in this study.

Where is the study run from?
Centre for Global Health Research, Diabetic Association of Bangladesh

When is the study starting and how long is it expected to run for?
April 2022 to April 2023

Who is funding the study?
Non-Communicable Disease Control Program of Directorate General of Health Services, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh.

Who is the main contact?
Dr Bishwajit Bhowmik, doctorbiplob@gmail.com

Contact information

Dr Bishwajit Bhowmik
Scientific

122, Kazi Nazrul Islam Avenue Shahbag
Dhaka
1000
Bangladesh

ORCiD logoORCID ID 0000-0003-1114-5873
Phone +880 1819287912
Email doctorbiplob@gmail.com

Study information

Study designMulticenter Interventional randomized controlled trial
Primary study designInterventional
Secondary study designCluster randomised trial
Study setting(s)Community
Study typePrevention
Participant information sheet 41624 PIS.pdf
Scientific titlePrevention of diabetes and related NCDs through religious leaders
Study acronymDPRL
Study hypothesisFaith-based intervention by religious leaders can affect the prevention of T2DM and related NCD risk factors.
Ethics approval(s)Approved 19/04/2022, The Ethical Review Committee (ERC) of the Diabetic Association of Bangladesh (BADAS, 122 Kazi Nazrul Islam Avenue, Shahbag, Dhaka-1000, Bangladesh; +880-2-9661551; ERC@dab-bd.org), ref: BADAS-ERC/EC 122100330
ConditionPrevention of diabetes
InterventionParticipants will be allocated at random in a 1:1 ratio.
Intervention arm: provide healthy lifestyle information through religious sermon (khutbah) plus person-specific dietary and physical activity advice;
Control arm: only provide healthy lifestyle information through religious sermon (khutbah)
Follow up is for 12 months
Intervention typeBehavioural
Primary outcome measureRate of conversion from prediabetes to T2DM using blood glucose (both fasting and 2 hours after 75-gram blood glucose drink) among the study population at 4 months and 12 months
Secondary outcome measures1. Rate of T2DM between intervention and control group using blood glucose at 4 months and 12 months
2. Rate of cardiometabolic parameters including obesity (general and abdominal) by measuring anthropometric parameters, HTN by measuring blood pressure, and dyslipidemia by measuring fasting lipid profile between intervention and control group at 4 months and 12 months
3. Changes in physical activity, and dietary habits between intervention and control group using face-to-face interview (control group) and both face to face interview and guidebook at 4 months and 12 months
4. Level of changes in knowledge, attitude, and practice about T2DM and related cardiometabolic parameters among the study participants using the questionnaire at 4 months and 12 months
Overall study start date19/04/2022
Overall study end date06/04/2023

Eligibility

Participant type(s)Healthy volunteer
Age groupAdult
SexBoth
Target number of participants824 (intervention arm:412 & control arm: 412); equal number in all 8 centers.
Participant inclusion criteria1. All individuals aged ≥25 years with diabetes risk score ≥9 and diagnosed with prediabetes (IFG/IGT) as per WHO recommended diagnostic value.
2. Both genders
3. Permanent residents
4. Willing to participate and available for 12 months of study
Participant exclusion criteria1. Pregnant women or planned pregnancy and lactating mothers
2. Known case of T2DM
3. Individuals diagnosed with acute physical or mental illness at the time of screening
Recruitment start date07/05/2022
Recruitment end date07/06/2022

Locations

Countries of recruitment

  • Bangladesh

Study participating centre

Centre for Global Health Research, Diabetic Association of Bangladesh
122, Kazi Nazrul Islam Avenue Shahbag
Dhaka
1000
Bangladesh

Sponsor information

Ministry of Health and Family Welfare
Government

Non-Communicable Disease Control Program of Directorate General of Health Services
Government of the People's Republic of Bangladesh
Mohakhali
Dhaka
1212
Bangladesh

Phone +880 222229207
Email ncdc@ld.dghs.gov.bd
Website http://www.mohfw.gov.bd/
ROR logo "ROR" https://ror.org/05256fm24

Funders

Funder type

Government

Ministry of Health and Family Welfare, Bangladesh

No information available

Results and Publications

Intention to publish date01/10/2023
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal
IPD sharing planThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request
doctorbiplob@gmail.com

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Other files 04/05/2022 No No
Other files 04/05/2022 No Yes
Participant information sheet 04/05/2022 No Yes
Protocol file 12/04/2022 04/05/2022 No No

Additional files

41624 PROTOCOL 12Apr2022.pdf
41624 Participant follow-up guide.pdf
41624 PIS.pdf
41624 Religious Sermon (Khutbah).pdf

Editorial Notes

09/05/2022: Internal review.
04/05/2022: Trial's existence confirmed by Diabetic Association of Bangladesh